Molecular Modeling of p38α Mitogen-Activated Protein Kinase Inhibitors through 3D-QSAR and Molecular Dynamics Simulations
暂无分享,去创建一个
[1] T. Darden,et al. Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .
[2] G. Klebe,et al. Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.
[3] V. Hornak,et al. Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.
[4] G. Scapin,et al. Lattice stabilization and enhanced diffraction in human p38 alpha crystals by protein engineering. , 2004, Biochimica et biophysica acta.
[5] Philip R. Cohen,et al. Activation of stress‐activated protein kinase‐3 (SAPK3) by cytokines and cellular stresses is mediated via SAPKK3 (MKK6); comparison of the specificities of SAPK3 and SAPK2 (RK/p38) , 1997, The EMBO journal.
[6] Wei Zhang,et al. A point‐charge force field for molecular mechanics simulations of proteins based on condensed‐phase quantum mechanical calculations , 2003, J. Comput. Chem..
[7] J. Hsuan,et al. Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of hsp27 , 1994, Cell.
[8] P. Kollman,et al. Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. , 2001, Journal of the American Chemical Society.
[9] E. Purisima,et al. A combined crystallographic and molecular dynamics study of cathepsin L retrobinding inhibitors. , 2009, Journal of medicinal chemistry.
[10] Baohua Ji,et al. Coarse-grained molecular dynamics of ligands binding into protein: The case of HIV-1 protease inhibitors. , 2009, The Journal of chemical physics.
[11] A. Cuenda,et al. p38 MAP-kinases pathway regulation, function and role in human diseases. , 2007, Biochimica et biophysica acta.
[12] C. Ambrosino,et al. Cell cycle regulation by p38 MAP kinases , 2001, Biology of the cell.
[13] Araz Jakalian,et al. Fast, efficient generation of high‐quality atomic charges. AM1‐BCC model: I. Method , 2000 .
[14] Philip R. Cohen,et al. Activation of the novel stress‐activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6); comparison of its substrate specificity with that of other SAP kinases , 1997, The EMBO journal.
[15] Jiahuai Han,et al. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. , 1996, Biochemical and biophysical research communications.
[16] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[17] D. Rotstein,et al. Discovery of S-[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)phenyl]methanone (RO3201195), an orally bioavailable and highly selective inhibitor of p38 MAP kinase. , 2006, Journal of medicinal chemistry.
[18] G. Narahari Sastry,et al. Sequence, Structure, and Active Site Analyses of p38 MAP Kinase: Exploiting DFG-out Conformation as a Strategy to Design New Type II Leads , 2011, J. Chem. Inf. Model..
[19] J. Dean,et al. The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look , 2012, The open rheumatology journal.
[20] Ying Yang,et al. Molecular Dynamics Simulation and Free Energy Calculation Studies of the Binding Mechanism of Allosteric Inhibitors with p38α MAP Kinase , 2011, J. Chem. Inf. Model..
[21] Jerry L. Adams,et al. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis , 1994, Nature.
[22] Yong Jiang,et al. Characterization of the Structure and Function of the Fourth Member of p38 Group Mitogen-activated Protein Kinases, p38δ* , 1997, The Journal of Biological Chemistry.
[23] D. Bulavin,et al. Deregulation of p53/p21Cip1/Waf1 pathway contributes to polyploidy and apoptosis of E1A+cHa-ras transformed cells after γ-irradiation , 1999, Oncogene.
[24] P. Kollman,et al. Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.
[25] L. McCabe,et al. p38 and Activating Transcription Factor-2 Involvement in Osteoblast Osmotic Response to Elevated Extracellular Glucose* , 2002, The Journal of Biological Chemistry.
[26] Sílvia G. Estácio,et al. Characterizing the Dynamics and Ligand-Specific Interactions in the Human Leukocyte Elastase through Molecular Dynamics Simulations , 2011, J. Chem. Inf. Model..
[27] Wei Guo,et al. Characterization of the Structure and Function of a New Mitogen-activated Protein Kinase (p38β)* , 1996, The Journal of Biological Chemistry.
[28] Z. Brown,et al. p38 MAPK signalling cascades in inflammatory disease. , 1999, Molecular medicine today.
[29] D. Case,et al. Exploring protein native states and large‐scale conformational changes with a modified generalized born model , 2004, Proteins.
[30] K. Chung,et al. p38 mitogen-activated protein kinase pathways in asthma and COPD. , 2011, Chest.
[31] E. Vasiliauskas,et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease. , 1999, Gastroenterology.
[32] G. Ciccotti,et al. Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .
[33] J. Woodgett,et al. The stress-activated protein kinase pathways , 1999, Cellular and Molecular Life Sciences CMLS.
[34] B. Williams,et al. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons , 1999, The EMBO journal.
[35] Annamaria Lilienkampf,et al. A 3D QSAR Model of 17β‐HSD1 Inhibitors Based on a Thieno[2,3‐d]pyrimidin‐4(3H)‐one Core Applying Molecular Dynamics Simulations and Ligand–Protein Docking , 2008, ChemMedChem.
[36] R. Cramer,et al. Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.
[37] U. Moens,et al. Mitogen-activated protein kinase p38 and MK2, MK3 and MK5: ménage à trois or ménage à quatre? , 2010, Cellular signalling.